×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ASRT – assertio holdings, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ASRT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
08:45 am
asrt
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors [Yahoo! Finance]
Low
Report
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors [Yahoo! Finance]
12/17
08:30 am
asrt
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
Low
Report
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
12/16
08:06 am
asrt
Assertio Holdings, Inc. (NASDAQ: ASRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Low
Report
Assertio Holdings, Inc. (NASDAQ: ASRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
12/13
08:00 am
asrt
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
Medium
Report
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
12/12
08:17 am
asrt
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO [Yahoo! Finance]
Medium
Report
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO [Yahoo! Finance]
12/12
08:00 am
asrt
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
Low
Report
Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO
11/29
06:51 am
asrt
New Strong Buy Stocks for November 29th [Yahoo! Finance]
Medium
Report
New Strong Buy Stocks for November 29th [Yahoo! Finance]
11/25
08:04 am
asrt
Assertio Holdings, Inc. (NASDAQ: ASRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Medium
Report
Assertio Holdings, Inc. (NASDAQ: ASRT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/17
05:01 pm
asrt
Form 8-K Assertio Holdings, Inc. For: Dec 12
Medium
Report
Form 8-K Assertio Holdings, Inc. For: Dec 12
11/19
09:02 am
asrt
Form 4 Assertio Holdings, Inc. For: Nov 18 Filed by: Mason Heather L
High
Report
Form 4 Assertio Holdings, Inc. For: Nov 18 Filed by: Mason Heather L
11/15
02:44 pm
asrt
Form 4 Assertio Holdings, Inc. For: Nov 14 Filed by: O'Grady Brendan P.
Low
Report
Form 4 Assertio Holdings, Inc. For: Nov 14 Filed by: O'Grady Brendan P.
11/14
04:56 pm
asrt
Form SCHEDULE 13G/A Assertio Holdings, Inc. Filed by: Nantahala Capital Management, LLC
Medium
Report
Form SCHEDULE 13G/A Assertio Holdings, Inc. Filed by: Nantahala Capital Management, LLC
11/14
03:53 pm
asrt
Form SC 13G/A Assertio Holdings, Inc. Filed by: ARMISTICE CAPITAL, LLC
Low
Report
Form SC 13G/A Assertio Holdings, Inc. Filed by: ARMISTICE CAPITAL, LLC
11/12
06:01 pm
asrt
Form 4 Assertio Holdings, Inc. For: Nov 07 Filed by: Stark David Matthew
Low
Report
Form 4 Assertio Holdings, Inc. For: Nov 07 Filed by: Stark David Matthew
11/12
06:00 pm
asrt
Form 3 Assertio Holdings, Inc. For: Nov 07 Filed by: Stark David Matthew
Low
Report
Form 3 Assertio Holdings, Inc. For: Nov 07 Filed by: Stark David Matthew
11/12
01:35 pm
asrt
Form SC 13G/A Assertio Holdings, Inc. Filed by: VANGUARD GROUP INC
Low
Report
Form SC 13G/A Assertio Holdings, Inc. Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/12
Assertio Therapeutics Announces Sale of Gralise® for Total Transaction Value of $127.5 Million
48.2%
2/6 Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million 46.2%
3/11 Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024 22.4%
12/13 Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) [Yahoo! Finance News] 15.7%
3/25 Form SC TO-I/A Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc 14.9%
11/12 Form SC 13G Assertio Therapeutics, Filed by: D. E. SHAW & CO, L.P. 11.2%
8/20 Form 4 Assertio Therapeutics, For: Aug 19 Filed by: HIGGINS ARTHUR J 10.9%
2/19 Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt 9.5%
4/24 Form 8-K Assertio Therapeutics, For: Apr 22 9.1%
10/5 How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? [Yahoo! Finance News] 9.0%
2/6 Assertio Therapeutics Announces Sale of NUCYNTA® Franchise to Collegium Pharmaceutical for $375.0 Million 46.2%
3/11 Assertio Therapeutics Announces Offer to Purchase All of Its Issued and Outstanding 2.50% Senior Convertible Notes Due 2021 and 5.00% Senior Convertible Notes Due 2024 22.4%
12/13 Hedge Funds Are Crazy About Assertio Therapeutics, Inc. (ASRT) [Yahoo! Finance News] 15.7%
3/25 Form SC TO-I/A Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc 14.9%
11/12 Form SC 13G Assertio Therapeutics, Filed by: D. E. SHAW & CO, L.P. 11.2%
8/20 Form 4 Assertio Therapeutics, For: Aug 19 Filed by: HIGGINS ARTHUR J 10.9%
2/19 Assertio Therapeutics Announces Repurchase of Approximately $188.0 Million of its Outstanding Convertible Debt 9.5%
4/24 Form 8-K Assertio Therapeutics, For: Apr 22 9.1%
10/5 How Does Assertio Therapeutics, Inc. (NASDAQ:ASRT) Affect Your Portfolio Volatility? [Yahoo! Finance News] 9.0%
TOP News Decliners
8/9
Assertio Therapeutics, Inc (ASRT) Q2 2019 Earnings Call Transcript [The Motley Fool]
-45.9%
3/9 Q4/2019 12/31/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat -30.8%
10/21 Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin -24.9%
8/20 Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference -17.4%
10/30 Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 -15.0%
11/6 Assertio Therapeutics, Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] -12.2%
3/2 Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020 -11.8%
1/13 Form 8-K Assertio Therapeutics, For: Jan 10 -9.4%
4/21 Form 425 Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc -7.9%
5/9 Form 4 Assertio Therapeutics, For: May 09 Filed by: MCKEE WILLIAM -7.7%
3/9 Q4/2019 12/31/2019 EPS -0.140 ZacksConsensus -0.220 ActVsEst 0.080 - Beat -30.8%
10/21 Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin -24.9%
8/20 Assertio Therapeutics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference -17.4%
10/30 Ceridian HCM Holding, BJ's Wholesale Club Holdings Set to Join S&P MidCap 400; Oceaneering International, Covetrus to Join S&P SmallCap 600 -15.0%
11/6 Assertio Therapeutics, Inc. 2019 Q3 - Results - Earnings Call Presentation [Seeking Alpha] -12.2%
3/2 Assertio Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results After the Close of Markets on Monday, March 9, 2020 -11.8%
1/13 Form 8-K Assertio Therapeutics, For: Jan 10 -9.4%
4/21 Form 425 Assertio Therapeutics, Filed by: Assertio Therapeutics, Inc -7.9%
5/9 Form 4 Assertio Therapeutics, For: May 09 Filed by: MCKEE WILLIAM -7.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: